PODD

Insulet Corporation [PODD] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

PODD Stock Summary

Top 10 Correlated ETFs

PODD

Top 10 Correlated Stocks

PODD

In the News

PODD Financial details

Company Rating
-
Market Cap
12.27B
Income
206.3M
Revenue
1.7B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
3K
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
119.09
Forward P/E
-
PEG
0.27
P/S
9.18
P/B
23.52
P/C
-
P/FCF
-1143.39
Quick Ratio
2.12
Current Ratio
3.26
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
2.95
EPS next Y
-
EPS next Q
-
EPS this Y
4364.56%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
73.18%
Revenue last 5Y
18.12%
Revenue Q/Q
17.82%
EPS Q/Q
100%
-
-
-
-
SMA20
-5.86%
SMA50
-7.67%
SMA100
9.47%
Inst Own
-
Inst Trans
-
ROA
5%
ROE
22%
ROC
0.05%
Gross Margin
65%
Oper. Margin
7%
Profit Margin
8%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
125.82-335.91
52W High
-11.23%
52W Low
+137.91%
RSI
48
Rel Volume
0.41
Avg Volume
864.81K
Volume
354.36K
Perf Week
4.14%
Perf Month
-2.3%
Perf Quarter
3.38%
Perf Half Y
7.79%
-
-
-
-
Beta
1.003
-
-
Volatility
3.42%, 9.15%
Prev Close
2.02%
Price
297.39
Change
1.63%

Something similar

Top by Market Cap
DHR-PB
META
APC.DE
ABEC.DE
AMZN
Top Correlated ETFs
HYMB
MLN
TAXF
JMUB
AVMU
Top Correlated Stocks
PNTG
PEN
GNE
FCNCP
LFST
Similar Market Cap
0LHS.L
002044.SZ
JYOTISTRUC.NS
BURL
0RU6.L

Company Profile

Healthcare Medical - Devices
  • Volume Average 864.81K
  • Market Capitalization 12.27B
  • Employee 3K
  • CEO Dr. James R. Hollingshead Ph.D.
  • Headquarters Acton,MA,US
  • IPO Date 2007-05-15
  • Website https://www.insulet.com

Insulet Corporation develops, manufactures, and sells insulin delivery systems for people with insulin-dependent diabetes. It offers Omnipod System, a self-adhesive disposable tubeless Omnipod device that is worn on the body for up to three days at a time, as well as its wireless companion, the handheld personal diabetes manager. The company sells its products primarily through independent distributors and pharmacy channels, as well as directly in the United States, Canada, Europe, the Middle East, and Australia. Insulet Corporation was incorporated in 2000 and is headquartered in Acton, Massachusetts.